Viral apoptotic mimicry: An immune evasion strategy developed by the hepatitis B virus?

Trends in Immunology

Volumn 24, Issue 3, 2003, Pages 144-147

  Vanlandschoot, Peter ^a   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; EUKARYOTIC CELL; EVOLUTION; HEPATITIS B VIRUS; IMMUNE RESPONSE; MOLECULAR MECHANICS; MOLECULAR MIMICRY; NONHUMAN; REVIEW; VIRUS INFECTION;

EID: 0037373640     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00026-7     Document Type: Review

References (39)

1. Fiers W., et al. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 18:1999;7719-7730.
2. Tortorella D., et al. Viral subversion of the immune system. Annu. Rev. Immunol. 18:2000;861-926.
3. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Trends Microbiol. 3:2000;379-386.
4. Milich D.R. Immune response to the hepatitis B virus: infection, animal models, vaccination. Viral Hepatitis. Rev. 3:1997;63-103.
5. Livingston B.D., et al. Altered helper T-lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J. Immunol. 162:1999;3088-3095.
6. Akbar S.M., et al. Dendritic cells and chronic hepatitis virus carriers. Intervirology. 44:2001;199-208.
7. Jochum C., et al. Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J. Virol. 64:1990;1956-1963.
8. Vanlandschoot P., et al. Hepatitis B surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J. Gen. Virol. 83:2002;1281-1289.
9. Vanlandschoot P., et al. Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced phosphorylation of ERK-1/2 and JNK-1/2 in monocytes. Biochem. Biophys. Res. Commun. 297:2002;486-491.
10. 2 and PAF. J. Clin. Invest. 101:1998;890-898.
11. McDonald P.P., et al. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells. J. Immunol. 163:1999;6164-6172.
12. Voll R.E., et al. Immunosuppressive effects of apoptotic cells. Nature. 390:1997;350-351.
13. Byrne A., Reen D.J. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 168:2002;1968-1977.
14. Fadok V.A., et al. Phagocyte receptors for apoptotic cells: recognition, uptake and consequences. J. Clin. Invest. 108:2001;957-962.
15. Manfredi A.A., et al. The disposal of dying cells in living tissues. Apoptosis. 7:2002;153-161.
16. Franc N.C. Phagocytosis of apoptotic cells in mammals Caenorhabditis elegans and Drosophila melanogaster: molecular mechanisms and physiological consequences. Front. Biosci. 7:2002;1298-1313.
17. Gorgani N.N., et al. Histidine-rich glycoprotein binds to DNA and FcγRI and potentiates the ingestion of apoptotic cells by macrophages. J. Immunol. 169:2002;4745-4751.
18. Webb J.H., et al. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J. Immunol. 169:2002;2580-2586.
19. Hazen S.L., Chisolm G.M. Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 99:2002;12515-12517.
20. Kagan V.A., et al. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169:2002;487-499.
21. Familian A., et al. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167:2001;647-654.
22. Gavilanes F., et al. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J. Biol. Chem. 257:1982;7770-7777.
23. Lozier J., et al. Complete amino-acid sequence of human β2-glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 81:1984;3640-3644.
24. Price B.E., et al. Anti-phospholipid autoantibodies bind to apoptotic but not viable thymocytes in a β2-glycoprotein I-dependent manner. J. Immunol. 157:1996;2201-2208.
25. Balasubramanian K., et al. Immune clearance of phophatidylsreine-expressing cells by phagocytes. The role of β2-glycoprotein I in macrophage recognition. J. Biol. Chem. 272:1997;31113-31117.
26. Balasubramanian K., Schroit A.J. Characterization of phosphatidylserine-dependent β2-glycoprotein I macrophage interactions. Implications for apoptotic-cell clearance by phagocytes. J. Biol. Chem. 273:1998;29272-29277.
27. Mehdi M., et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J. Virol. 68:1994;2415-2424.
28. Mehdi M., et al. An altered form of apolipoprotein H binds hepatitis B surface antigen most efficiently. Virology. 217:1996;58-66.
29. Stefas I., et al. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology. 33:2001;207-217.
30. Gregory C.D. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 12:2000;27-34.
31. Vanlandschoot P., et al. LPS binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J. Gen. Virol. 83:2002;2279-2289.
32. Mevorach D., et al. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188:1998;2313-2320.
33. Milich D.R., et al. Interactions between polymerized human albumin, hepatitis B surface antigen and complement: II. Involvement of C1q in or near the hepatitis B surface antigen receptor for polyalbumin. J. Med. Virol. 7:1981;193-204.
34. Ogden C.A., et al. C1q and mannose binding lectin engagement of cell-surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:2001;781-795.
35. Vandivier R.W., et al. Role of surfactant proteins A, D and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:2002;3978-3986.
36. Gershov D., et al. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192:2000;1353-1364.
37. Nauta A.J., et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32:2002;1726-1736.
38. Steinman R.M., et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:2000;411-416.
39. Morelli A.E., et al. Internalization of circulating apoptotic cells by splenic marginal-zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood. 101:2003;611-620.